Research summary ·
Racial, Ethnic and Sex Representation in Tourette's Syndrome Clinical Trials: A Meta-Analysis.
Written based on 1 research study on PubMed, searched on 13 Nov 2026.
What was studied
This study looked at who takes part in drug trials for Tourette's Syndrome. The team checked if each race, ethnic group and sex took part fairly. They searched several study databases for trials done in the US. Only trials where people were put into groups by chance were used. This is a meta-analysis, which pools data from many studies. For each group, they compared its share in trials with its share in the US.
What they found
The team found 40 trials with 1717 people in total. All trials gave the sex of the people in them. Only 22 trials gave race, and only 12 gave ethnic group. Reporting of race and ethnic group got better with time. Asian, Black and Hispanic people were all under-included in these trials. Females were also under-included. Only the share of Hispanic people taking part grew with time.
What it means for patients
The authors say these trials do not fairly reflect race, ethnic group and sex. They say the low number of minority people may have more than one cause. Fewer of them may get a diagnosis of the condition. Or fewer may be asked to join research studies. It could also be both of these at once.
Why it is not certain yet
Many trials did not report race or ethnic group. So the picture for race and ethnic group rests on fewer trials. The study only looked at trials done in the US. The abstract does not say for sure why the gaps exist. A review can only be as good as the studies in it.
Source
Racial, Ethnic and Sex Representation in Tourette's Syndrome Clinical Trials: A Meta-Analysis.
PubMed · PMID 41392858We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Tourette syndrome publications